New research has uncovered a hidden pathway that allows COVID-19 to infect the immune system and trigger damaging ...
Understanding inflammation—and, above all, how to regulate it—is one of the great medical challenges of modern medicine. Its ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
The Princess of Wales completed the Three Peaks challenge to raise money for the hospital where she was treated ...
Omeros Corporation (Nasdaq: OMER) announced today an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company’s marketing ...
Researchers at IIT Kanpur, led by Professor Arun K Shukla, have uncovered the molecular basis underlying the atypical ...
The transaction transforms Nuvectis into a late-stage clinical development company by expanding its pipeline into complement-mediated diseases ...
Detailed price information for Geovax Labs Inc (GOVX-Q) from The Globe and Mail including charting and trades.
Scientists are getting closer to figuring out how amyloid immunotherapy causes ARIA, and perhaps how to prevent it. At last month’s AD/PD conference in Copenhagen, Denmark, the spotlight was on innate ...
C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
Although many things can affect your individual prognosis, about half of all patients will reach kidney failure within 10 years of their diagnosis and need dialysis or a kidney transplant. Even after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results